Doripénem (DORIBAX) : new recommendations

The European Medicines Agency  informs doctors that the currently recommended dose of DORIBAX for the treatment of nosocomial pneumonia may be not sufficient in severe cases. A letter for the attention of health professionals will be sent to prescribers informing them of these new recommendations.

Press release EMA

Contact
vig@afmps.be


 

Last updated on 29/01/2013